FDA rejected Moderna’s mRNA flu vaccine due to flawed trial design and comparator, raising concerns over regulatory consistency and innovation.

Cats and humans share key cancer genes, with study revealing similar tumor mutations and treatment responses, advancing precision medicine for both.

A promising nasal spray vaccine in mice offers broad, long-lasting protection against flu, COVID-19, colds, pneumonia, and allergens with just one dose, potentially eliminating annual shots, but human trials are still needed.

Johnson & Johnson invests $1B in Pennsylvania to build a cell therapy plant, creating 4,500 jobs, part of a broader U.S. push for domestic advanced medicine manufacturing.

FDA to shift from two to one clinical trial for most new drug approvals to accelerate access.

A Tetris-like game played after recalling trauma cuts flashbacks by 90%, offering a simple, scalable PTSD tool.

A small 2026 trial found DMT therapy rapidly reduced depression symptoms for up to six months in treatment-resistant adults.

Medtronic beat profit expectations in Q3 2026, driven by strong heart and diabetes device sales, and reaffirmed its 2026 earnings outlook.

Pharmac proposes funding two CLL combo therapies in NZ from May 1, 2026, following public consultation.

Pennsylvania Hospital will open as a public museum in May 2026 to celebrate its 275th anniversary with interactive exhibits on its medical history.